vs
RIGEL PHARMACEUTICALS INC(RIGL)与null(SWIM)财务数据对比。点击上方公司名可切换其他公司
null的季度营收约是RIGEL PHARMACEUTICALS INC的1.7倍($117.3M vs $69.8M),RIGEL PHARMACEUTICALS INC净利率更高(384.0% vs -7.3%,领先391.3%),RIGEL PHARMACEUTICALS INC同比增速更快(21.2% vs 5.3%),过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高(53.7% vs -14.4%)
Rigel制药是一家临床阶段生物技术企业,专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法,核心市场位于美国,旗下已获批产品可治疗成人免疫性血小板减少症,致力于满足未被覆盖的临床医疗需求。
该企业是一家源自美国的跨国律师事务所,1934年创立于加利福尼亚州洛杉矶,在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度,是全球颇具影响力的综合性律所之一。
RIGL vs SWIM — 直观对比
营收规模更大
SWIM
是对方的1.7倍
$69.8M
营收增速更快
RIGL
高出15.9%
5.3%
净利率更高
RIGL
高出391.3%
-7.3%
两年增速更快
RIGL
近两年复合增速
-14.4%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $69.8M | $117.3M |
| 净利润 | $268.1M | $-8.5M |
| 毛利率 | 91.5% | 31.7% |
| 营业利润率 | 33.2% | — |
| 净利率 | 384.0% | -7.3% |
| 营收同比 | 21.2% | 5.3% |
| 净利润同比 | 1769.2% | -43.1% |
| 每股收益(稀释后) | $14.11 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
RIGL
SWIM
| Q1 26 | — | $117.3M | ||
| Q4 25 | $69.8M | $100.0M | ||
| Q3 25 | $69.5M | $161.9M | ||
| Q2 25 | $101.7M | $172.6M | ||
| Q1 25 | $53.3M | $111.4M | ||
| Q4 24 | $57.6M | $87.3M | ||
| Q3 24 | $55.3M | $150.5M | ||
| Q2 24 | $36.8M | $160.1M |
净利润
RIGL
SWIM
| Q1 26 | — | $-8.5M | ||
| Q4 25 | $268.1M | $-7.0M | ||
| Q3 25 | $27.9M | $8.1M | ||
| Q2 25 | $59.6M | $16.0M | ||
| Q1 25 | $11.4M | $-6.0M | ||
| Q4 24 | $14.3M | $-29.2M | ||
| Q3 24 | $12.4M | $5.9M | ||
| Q2 24 | $-1.0M | $13.3M |
毛利率
RIGL
SWIM
| Q1 26 | — | 31.7% | ||
| Q4 25 | 91.5% | 28.0% | ||
| Q3 25 | 93.2% | 35.4% | ||
| Q2 25 | 95.6% | 37.1% | ||
| Q1 25 | 91.7% | 29.5% | ||
| Q4 24 | 89.9% | 24.6% | ||
| Q3 24 | 85.5% | 32.4% | ||
| Q2 24 | 92.4% | 33.1% |
营业利润率
RIGL
SWIM
| Q1 26 | — | — | ||
| Q4 25 | 33.2% | -10.7% | ||
| Q3 25 | 40.9% | 13.3% | ||
| Q2 25 | 60.1% | 14.3% | ||
| Q1 25 | 23.9% | -4.4% | ||
| Q4 24 | 28.9% | -14.9% | ||
| Q3 24 | 25.4% | 8.9% | ||
| Q2 24 | 1.2% | 12.5% |
净利率
RIGL
SWIM
| Q1 26 | — | -7.3% | ||
| Q4 25 | 384.0% | -7.0% | ||
| Q3 25 | 40.2% | 5.0% | ||
| Q2 25 | 58.6% | 9.3% | ||
| Q1 25 | 21.5% | -5.4% | ||
| Q4 24 | 24.9% | -33.4% | ||
| Q3 24 | 22.5% | 3.9% | ||
| Q2 24 | -2.8% | 8.3% |
每股收益(稀释后)
RIGL
SWIM
| Q1 26 | — | $-0.07 | ||
| Q4 25 | $14.11 | $-0.06 | ||
| Q3 25 | $1.46 | $0.07 | ||
| Q2 25 | $3.28 | $0.13 | ||
| Q1 25 | $0.63 | $-0.05 | ||
| Q4 24 | $0.82 | $-0.24 | ||
| Q3 24 | $0.70 | $0.05 | ||
| Q2 24 | $-0.06 | $0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $155.0M | — |
| 总债务越低越好 | $52.5M | $3.3M |
| 股东权益账面价值 | $391.5M | $396.7M |
| 总资产 | $513.6M | $856.4M |
| 负债/权益比越低杠杆越低 | 0.13× | 0.01× |
8季度趋势,按日历期对齐
现金及短期投资
RIGL
SWIM
| Q1 26 | — | — | ||
| Q4 25 | $155.0M | — | ||
| Q3 25 | $137.1M | — | ||
| Q2 25 | $108.4M | — | ||
| Q1 25 | $77.1M | — | ||
| Q4 24 | $77.3M | — | ||
| Q3 24 | $61.1M | — | ||
| Q2 24 | $49.1M | — |
总债务
RIGL
SWIM
| Q1 26 | — | $3.3M | ||
| Q4 25 | $52.5M | $279.8M | ||
| Q3 25 | $60.0M | $281.1M | ||
| Q2 25 | $60.0M | $281.5M | ||
| Q1 25 | $60.0M | $306.9M | ||
| Q4 24 | $60.0M | $281.5M | ||
| Q3 24 | $60.0M | $282.8M | ||
| Q2 24 | $60.0M | $282.4M |
股东权益
RIGL
SWIM
| Q1 26 | — | $396.7M | ||
| Q4 25 | $391.5M | $405.9M | ||
| Q3 25 | $117.6M | $408.4M | ||
| Q2 25 | $81.9M | $398.4M | ||
| Q1 25 | $18.6M | $381.1M | ||
| Q4 24 | $3.3M | $387.2M | ||
| Q3 24 | $-14.6M | $416.6M | ||
| Q2 24 | $-29.9M | $408.1M |
总资产
RIGL
SWIM
| Q1 26 | — | $856.4M | ||
| Q4 25 | $513.6M | $823.2M | ||
| Q3 25 | $242.5M | $844.4M | ||
| Q2 25 | $206.7M | $822.1M | ||
| Q1 25 | $176.0M | $824.6M | ||
| Q4 24 | $164.0M | $794.2M | ||
| Q3 24 | $139.4M | $853.4M | ||
| Q2 24 | $128.4M | $830.0M |
负债/权益比
RIGL
SWIM
| Q1 26 | — | 0.01× | ||
| Q4 25 | 0.13× | 0.69× | ||
| Q3 25 | 0.51× | 0.69× | ||
| Q2 25 | 0.73× | 0.71× | ||
| Q1 25 | 3.23× | 0.81× | ||
| Q4 24 | 18.25× | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $22.0M | $-47.7M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 0.08× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
RIGL
SWIM
| Q1 26 | — | $-47.7M | ||
| Q4 25 | $22.0M | $23.3M | ||
| Q3 25 | $24.0M | $51.0M | ||
| Q2 25 | $30.5M | $36.0M | ||
| Q1 25 | $-893.0K | $-46.9M | ||
| Q4 24 | $14.5M | $6.2M | ||
| Q3 24 | $21.7M | $37.2M | ||
| Q2 24 | $302.0K | $52.4M |
自由现金流
RIGL
SWIM
| Q1 26 | — | — | ||
| Q4 25 | — | $14.1M | ||
| Q3 25 | — | $45.2M | ||
| Q2 25 | — | $29.1M | ||
| Q1 25 | — | $-50.3M | ||
| Q4 24 | — | $-98.0K | ||
| Q3 24 | — | $33.2M | ||
| Q2 24 | — | $47.9M |
自由现金流率
RIGL
SWIM
| Q1 26 | — | — | ||
| Q4 25 | — | 14.1% | ||
| Q3 25 | — | 27.9% | ||
| Q2 25 | — | 16.8% | ||
| Q1 25 | — | -45.2% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 22.1% | ||
| Q2 24 | — | 29.9% |
资本支出强度
RIGL
SWIM
| Q1 26 | — | — | ||
| Q4 25 | — | 9.2% | ||
| Q3 25 | — | 3.6% | ||
| Q2 25 | — | 4.0% | ||
| Q1 25 | — | 3.1% | ||
| Q4 24 | — | 7.2% | ||
| Q3 24 | — | 2.7% | ||
| Q2 24 | — | 2.8% |
现金转化率
RIGL
SWIM
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.86× | 6.29× | ||
| Q2 25 | 0.51× | 2.25× | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | 1.01× | — | ||
| Q3 24 | 1.75× | 6.32× | ||
| Q2 24 | — | 3.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图